2. Journal Club with Dr. Jonathan Cachat: “The Potential for Kratom as an Antidepressant and Antipsychotic”

  • Post author:
  • Post category:
  • Post comments:0 Comments

This is the Kratom Science Journal Club with Dr. Jonathan Cachat, neuroscientist and expert in psychopharmacology. In each episode we discuss an article in a peer reviewed journal. For episode…

Continue Reading 2. Journal Club with Dr. Jonathan Cachat: “The Potential for Kratom as an Antidepressant and Antipsychotic”

28. Dr. Jonathan Cachat

  • Post author:
  • Post category:
  • Post comments:0 Comments

Dr. Jonathan Cachat is a neuroscientist and expert in psychopharmacology, who has extensively studied the effects of psychoactive substances on zebrafish. Dr. Cachat was involved in pioneering the first ever…

Continue Reading 28. Dr. Jonathan Cachat

20. Jennifer Van Blunk

  • Post author:
  • Post category:
  • Post comments:0 Comments

Jennifer Van Blunk is a Philly pastry chef. Years ago her dream of a career in the military was cut short due to an injury. After being discharged from the…

Continue Reading 20. Jennifer Van Blunk

8. Anonymous from Mississippi

  • Post author:
  • Post category:
  • Post comments:0 Comments

Kratom consumers are being threatened in Mississippi. A task force made up of law enforcement officers is lobbying county and town councils in an effort to ban kratom. They are…

Continue Reading 8. Anonymous from Mississippi

1. Gabrielle Callea

  • Post author:
  • Post category:
  • Post comments:0 Comments

The Kratom Science Podcast is your source for all things kratom. Each week Brian Gallagher, writer for KratomScience.com, talks to kratom consumers, advocates, and experts. We talk about the latest…

Continue Reading 1. Gabrielle Callea

PA House resolution seeking regulatory guidance from the FDA contains language explaining why it shouldn’t

A proposed resolution introduced to the Pennsylvania House on Tuesday, September 3rd would officially request guidelines for kratom regulation in the state from none other than the FDA. HR460's primary…

Continue Reading PA House resolution seeking regulatory guidance from the FDA contains language explaining why it shouldn’t